E(Erjola Bolleke (Likaj)

Erjola Bolleke (Likaj)

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erjola Bolleke (Likaj) has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Alma Idrizi

    Department of Nephrology, Dialysis and Transplantation, University Hospital Center 'Mother Theresa,' Tirana, Albania

    2 shared publications
  • Ermal Likaj

    Cardiac Surgery Department, Mother Teresa University, 1000 Tirana, Albania

    1 shared publication
  • Fjorba Mana

    Department of Cardiac Surgery, University Hospital Center 'Mother Theresa,' Tirana, Albania

    1 shared publication
  • Kristi Saliaj

    Department of Nephrology, Dialysis and Transplantation, University Hospital Center 'Mother Theresa,' Tirana, Albania

    1 shared publication
  • Merita Rroji

    University Department of Nephrology, Faculty of Medicine, University of Medicine Tirana, Tirana 1001, Albania

    1 shared publication
  • Myftar Barbullushi

    Nephrology and Dialysis Unit, UHC Mother Theresa, Tirana, Albania

    1 shared publication

Latest Publications

  • Open Access

    Combined right and left sided endocarditis in a hemodialysis patient: A cautionary tale

    by Erjola Bolleke (Likaj), Ermal Likaj, Saimir Seferi, Kristi Saliaj, Fjorba Mana, Selman Dumani, Alma Idrizi

    Introduction: Infective endocarditis is a potentially life-threatening condition, more prevalent among chronic maintenance hemodialysis patients, as opposed to the general population. Aim: Combined involvement of both the right and left heart chambers is exceptionally rare. Case study: Herein, we present the case of a patient on long-term maintenance hemodialysis with right and left sided infective endocarditis. Results and discussion: We discuss potential risk factors leading to the widespread infection and emphasize the importance of an early diagnosis and prompt treatment in yielding better outcomes. Conclusions: The patient was treated successfully by a multidisciplinary team.


  • Open Access

    Exhausting Multiple Hemodialysis Access Failures

    by Erjola Bolleke, Saimir Seferi, Merita Rroji, Alma Idrizi, Myftar Barbullushi, Nestor Thereska

    Vascular access is often considered the Achilles heel the of hemodialysis because of its impact on morbidity, all cause mortality and finally costs of these patients. The most common complication of permanent hemodialysis (HD) vascular access is thrombosis, with some cases being related to hypercoagulability states. Antiphospholipid antibody syndrome (APAS) is a cause of increased thrombotic tendency, and this may complicate the management of such patients on HD. We describe a 41-year-old woman with end stage renal disease (ESRD) from Adult Polycystic Kidney Disease who was referred to our tertiary care center for treatment and selection of renal replacement therapy form. It was thought to initiate with peritoneal dialysis considering her actual conditions. She was putted on hemodialysis for several sessions, and a subclavian cathether was her first vascular access. The surgeon created an arterio-venous fistula which did not mature. After the implantation of the peritoneal cathether she started peritoneal dialysis and continued living with that for 2 years. She felt exhausted and because of a grave peritonitis episode accompanied with procedure failure and a long hospitalization she was transferred to hemodialysis. Renal transplantation was not possible because she didn't have a kidney donation. She was maintained on regular HD, but her dialysis care was complicated by recurrent vascular access failures. She had multiple interventions for arterio-venous fistulas and grafts but almost all of them failed due to thrombosis to the extent that only one access site was available for her routine renal replacement treatment. A thorough thrombophilia screen confirmed the presence of antiphospholipid antibodies. A diagnosis of APAS was made and she was anticoagulated with warfarin. The AVG made in this last available site is still working from 18 months. If it fails we have no answers and solutions for her. The presence of APAS can complicate HD management by causing recurrent vascular access thrombosis and failure, and nephrologist must remain alert to this possibility. Checking and treating as soon as possible it's our future challenge.